Single-dose tetracycline labeling for bone histomorphometry
- PMID: 2499180
- DOI: 10.1093/ajcp/91.6.682
Single-dose tetracycline labeling for bone histomorphometry
Abstract
A single oral dose of tetracycline deposits in bone and is readily identified with fluorescence microscopy. Two such time-spaced labels can be used to determine bone dynamic features. This is as accurate as conventional three-day labeling periods. The simplicity, improved compliance, and substantial reduction in time it takes to prepare a patient for bone biopsy all appear to be advantageous when compared with current recommendations.
Similar articles
-
The tissue pathologic features of metabolic bone disease.Orthop Clin North Am. 1984 Oct;15(4):613-29. Orthop Clin North Am. 1984. PMID: 6493734
-
[Diagnosis of metabolic bone diseases: bone biopsy and bone histomorphometry].Nihon Rinsho. 1986 Nov;44(11):2461-6. Nihon Rinsho. 1986. PMID: 3546801 Review. Japanese. No abstract available.
-
Relationships of static and kinetic histomorphometric features of bone.Clin Orthop Relat Res. 1980 Jan-Feb;(146):239-45. Clin Orthop Relat Res. 1980. PMID: 6989538
-
The pathology of metabolic bone disease.Radiol Clin North Am. 1991 Jan;29(1):19-36. Radiol Clin North Am. 1991. PMID: 1985327 Review.
-
The tissue diagnosis of metabolic bone disease. Role of histomorphometry.Orthop Clin North Am. 1990 Jan;21(1):65-79. Orthop Clin North Am. 1990. PMID: 2296460
Cited by
-
Does bone change after biliopancreatic diversion?J Gastrointest Surg. 2002 Sep-Oct;6(5):690-8. doi: 10.1016/s1091-255x(01)00086-5. J Gastrointest Surg. 2002. PMID: 12399058
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources